APCs |
Antigen presenting cells |
BBB |
Blood brain barrier |
CAMs |
cell adhesion molecules |
CNS |
Central nervous system |
ECM |
Extracellular matrix |
EMT |
Epithelial–mesenchymal transition |
EGFR |
epidermal growth factors receptor |
FDA |
Food and Drug Administration |
GAG |
Glycosaminoglycans |
GAM |
Glioma-associated macrophage and microglia |
GASC |
Glioma Associated Stem cells |
GBM |
Glioblastoma |
GCS |
Glioma stem cells |
MET |
mesenchymal–epithelial transition |
PD1 |
Programmed cell Death-1 |
PRISMA-P |
Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols |
SIRT1 |
Sirtuin 1 |
TCR |
T cell receptors |
TGF-β |
Transforming growth factor-β |
TIL |
Tumor-infiltrating lymphocytes |
TME |
Tumor Microenvironment |
TMZ |
Temozolomide |